← New search

Other meanings of HIV testing

MEDICINE

HIV testing

HIV testing is medical testing to determine whether a person is infected with HIV. Tests detect antibodies, the viral p24 antigen, or HIV genetic material in blood or oral-fluid specimens. A reactive screening result requires follow-up testing before an HIV diagnosis is confirmed; a negative result may need repeating if exposure occurred recently.

3 main targets
antibody, antigen, or viral RNA
What tests detect
18–45 days
typical laboratory NAT window
Earliest common detection range
At least once
recommended for many adults
Routine screening principle
1

What the tests detect

HIV tests differ mainly in what biological signal they detect and how soon that signal appears. Antibody tests identify the immune response to HIV and are widely used in laboratory, clinic, and self-testing. Antigen/antibody tests also detect p24 antigen, a viral protein that can appear before antibodies. Nucleic acid tests (NATs) detect HIV RNA and can identify infection earliest, but they are generally used when very recent exposure or acute HIV infection is suspected rather than as the routine first test.1

Specimens may be collected from venous blood, a finger stick, or oral fluid. Laboratory fourth-generation tests commonly use venous blood, whereas some rapid and self-tests use oral fluid or finger-stick blood. Test choice depends on availability, timing, symptoms, exposure risk, and whether a clinician needs an especially early result.

2

Timing and interpretation

The timing of HIV testing determines how confidently a negative result can exclude infection. No test detects HIV immediately after exposure: NATs usually detect infection earlier than antigen/antibody tests, and antibody-only tests generally have the longest window period.1 A negative result obtained during this window may not be conclusive, so the test should be repeated according to the test type and the exposure date.

A reactive rapid or self-test is preliminary, not a diagnosis. It must be followed by a laboratory testing algorithm that distinguishes HIV-1 from HIV-2 and resolves an initially reactive result; a positive result is then used to begin care and additional evaluation.2 Symptoms resembling influenza shortly after exposure can occur during acute infection, but symptoms alone cannot establish HIV status.

3

Screening, privacy, and next steps

Routine screening makes HIV testing part of preventive health care rather than a test reserved for visible illness. The United States Preventive Services Task Force recommends screening adolescents and adults aged 15 to 65, with testing outside that range when individual risk or circumstances warrant it. Pregnant patients are screened because diagnosis allows treatment that greatly reduces perinatal transmission.

Testing may be offered in primary-care clinics, sexual-health services, community programs, hospitals, pharmacies, and homes. Counseling and consent practices vary by jurisdiction, while confidentiality protections generally govern clinical services. A person with a confirmed diagnosis should be linked promptly to antiretroviral therapy; people with a recent possible exposure may instead need urgent assessment for post-exposure prophylaxis (PEP). Partners may also benefit from testing, prevention counseling, and access to PrEP.

4

Lesser-known aspects

HIV testing has important edge cases that can make a seemingly simple result difficult to interpret. Antiretroviral medicines used for PrEP or PEP can sometimes suppress HIV replication and delay or complicate detection, so clinicians may select laboratory antigen/antibody testing and NAT follow-up rather than rely on a single rapid test.3 An indeterminate laboratory pattern can reflect very early infection, resolved or nonspecific reactivity, or technical issues; it is a reason for additional testing, not a diagnosis.

Testing also supports surveillance and public-health planning, but surveillance records and clinical records serve different purposes. HIV viral load testing measures the amount of virus after diagnosis and is not a substitute for an initial diagnostic test. Self-tests expand access and privacy, yet a reactive self-test still requires confirmatory care, and a negative self-test remains subject to its window period.

Glossary

Antibody test
A test that detects immune proteins produced in response to HIV infection.
Antigen/antibody test
A test that detects both HIV antibodies and the p24 antigen.
Nucleic acid test (NAT)
A test that detects HIV genetic material, usually RNA, in a specimen.
Window period
The interval after infection during which a test may remain negative despite HIV infection.
Reactive result
A preliminary result indicating that follow-up testing is required; it is not by itself a confirmed diagnosis.

Test availability, consent rules, confirmatory algorithms, and follow-up intervals vary by country and test brand. A clinician or qualified testing service can interpret results in relation to the exposure date and any antiretroviral medicines.